| For: | Carter CJ, Mekkawy AH, Morris DL. Role of human nucleoside transporters in pancreatic cancer and chemoresistance. World J Gastroenterol 2021; 27(40): 6844-6860 [PMID: 34790010 DOI: 10.3748/wjg.v27.i40.6844] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v27/i40/6844.htm |
| Number | Citing Articles |
| 1 |
Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159 doi: 10.1016/bs.acr.2023.02.010
|
| 2 |
Tejinder Kaur, Brenna Weadick, Thomas A. Mace, Kajal Desai, Hannah Odom, Rajgopal Govindarajan. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. Pharmacology & Therapeutics 2022; 240 doi: 10.1016/j.pharmthera.2022.108300
|
| 3 |
Binglin Sui, Junling Chen, Dian Ge, Feng Liang, Hongda Wang. Assembly Characterization of Human Equilibrium Nucleoside Transporter 1 (hENT1) by Inhibitor Probe-Based dSTORM Imaging. Analytical Chemistry 2023; 95(24) doi: 10.1021/acs.analchem.3c00596
|
| 4 |
Erika Y. Faraoni, Cynthia Ju, Simon C. Robson, Holger K. Eltzschig, Jennifer M. Bailey-Lundberg. Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.849258
|
| 5 |
Karyl K. Buddington, Stefan G. Pierzynowski, William E. Holmes, Randal K. Buddington. Selective and Concentrative Enteropancreatic Recirculation of Antibiotics by Pigs. Antibiotics 2023; 13(1) doi: 10.3390/antibiotics13010012
|
| 6 |
Md. Ratul Rahman, Kouji Hirota, Ryotaro Kawasumi. Proofreading exonuclease activity of replicative polymerase epsilon promotes cellular tolerance to arabinosides in CTF18-dependent and -independent manner. Genome Instability & Disease 2024; 5(2) doi: 10.1007/s42764-024-00124-w
|
| 7 |
Valeria Bincoletto, Ilaria Andreana, Barbara Stella, Nazanine Modjtahedi, Silvia Arpicco, Giorgia Urbinati. Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer. WIREs Nanomedicine and Nanobiotechnology 2026; 18(3) doi: 10.1002/wnan.70067
|
| 8 |
Nikoleta Iosifidou, Eleni Anagnostopoulou, Maria Botou, Eirini Kalfa, Ekaterini Tatsaki, Stathis Frillingos. Elucidation of the Gemcitabine Transporters of Escherichia coli K-12 and Gamma-Proteobacteria Linked to Gemcitabine-Related Chemoresistance. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137012
|
| 9 |
Amarah Sultan Rana, Nadeem Raza, Mehwish Abid, Muhammad Faizan Nazar. Surfactant-mediated carriers for gemcitabine: New insights and future prospects. Surfaces and Interfaces 2025; 77 doi: 10.1016/j.surfin.2025.108066
|
| 10 |
Debasis Nayak, Brenna Weadick, Rajgopal Govindarajan. Cancer Systems and Integrative Biology. Methods in Molecular Biology 2023; 2660 doi: 10.1007/978-1-0716-3163-8_8
|
| 11 |
Hongrui Fan, Hongyi Chen, Haolin Song, Chufeng Li, Yu Wang, Zhenhao Zhao, Qin Guo, Xuwen Li, Mingxuan Liu, Tao Sun, Chen Jiang. Cascade‐Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Advanced Science 2025; 12(38) doi: 10.1002/advs.202507118
|
| 12 |
Renshuai Zhang, Jun Zeng, Wenjing Liu, Jingsen Meng, Chao Wang, Lingyu Shi, Shanbo Yang, Jing Chang, Dongming Xing. The role of NPC1L1 in cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.956619
|
| 13 |
Ming Jin, Zhenzhen Cai, Ming Bu, Jicheng Liu, Xiaojie Zhang. From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1860957
|
| 14 |
Lucy J. Martinez-Guerrero, Patricia A. Vignaux, Dominique O. Farrera, Joshua S. Harris, Renuka Raman, Thomas R. Lane, Stephen H. Wright, Sean Ekins, Nathan J. Cherrington. Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2. The Journal of Pharmacology and Experimental Therapeutics 2025; 392(9) doi: 10.1016/j.jpet.2025.103660
|
| 15 |
Jiazhou Li, Ahmed E. Goda, Daniel Enriquez-Vera, Shuhei Fujii, Satomi Harazono, Jhajaira M. Araujo, Nao Nishikoba, Sophia Velarde, Atakan Zeki Namli, Alvaro De Jesus Huamani Ortiz, Shingo Nakahata. Synergistic effects of HDAC inhibitor tucidinostat and ENT inhibitor dipyridamole in T-cell malignancies. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-43642-1
|
| 16 |
Chunyuan Gan, Jingheng Xiang, Yao Liu, Shili Nie, Qin Hu, Lian Yi, Yu Liu, Xiao Guo, Jie Zou, Yaqin Tang, Jianguo Cui, Jing Xie. Nucleoside antitumor drugs: From molecular mechanisms and adaptive resistance to clinical translation. Biochemical Pharmacology 2026; 254 doi: 10.1016/j.bcp.2026.118501
|
| 17 |
Sara Alam, Emily Doherty, Paula Ortega-Prieto, Julia Arizanova, Louise Fets. Membrane transporters in cell physiology, cancer metabolism and drug response. Disease Models & Mechanisms 2023; 16(11) doi: 10.1242/dmm.050404
|
| 18 |
Asia Botto, Noa Ndimurwanko, Francesco Finamore, Annalisa Comandatore, Luca Morelli, Elisa Giovannetti, Liam A. McDonnell. Proteomics of
Extracellular Vesicles Derived from
Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies
Ribosomal Proteins Associated with Survival. Journal of Proteome Research 2026; 25(8) doi: 10.1021/acs.jproteome.6c00168
|
| 19 |
Aditya Ganju, Shyam Rao, Mark A. Dickson, Robert A. Lefkowitz, Chris Thompson, Jin Cheng, Katia Manova, Adriana Haimovitz-Friedman, Gary Schwartz, Zhigang Zhang, Zvi Fuks, William D. Tap, Richard Kolesnick. Enhancing gemcitabine uptake by promoting dimerization of ENT1 transporter improves response rates of patients with sarcoma. Journal of Clinical Investigation 2026; 136(20) doi: 10.1172/JCI183474
|
| 20 |
Yunchun Zhao, Shuya Ye, Yao Zhu, Yue Chen, Shan Yang, Fengmei Wang, Rong Wang, Dongxu Qin, Dongli Sun, Caihong Zheng. Advancement in transporter-oriented nanoplatforms for cancer therapy. Journal of Drug Targeting 2023; 31(5) doi: 10.1080/1061186X.2023.2197570
|
| 21 |
Wesley S. van de Geer, Ron H.J. Mathijssen, Job van Riet, Neeltje Steeghs, Mariette Labots, Carla van Herpen, Lot A. Devriese, Vivianne C.G. Tjan-Heijnen, Emile E. Voest, Stefan Sleijfer, John W.M. Martens, Edwin Cuppen, Harmen J.G. van de Werken, Sander Bins. Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors. Biomedicine & Pharmacotherapy 2023; 159 doi: 10.1016/j.biopha.2022.114210
|
| 22 |
Chunyang Bi, Florian Schwermer, Lu Tang, Christa E. Müller, Wukun Liu. Inhibitors of Ectonucleotidase CD39 for Immunotherapy of Cancer and Infections─Recent Developments and Future Perspectives. Journal of Medicinal Chemistry 2026; 69(9) doi: 10.1021/acs.jmedchem.6c00078
|
| 23 |
Sila Appak Baskoy, Amardeep Khunkhuna, Bianca Scuric, Zlatina Tarmakova, Imogen R Coe. Characterization of equilibrative nucleoside transport of the pancreatic cancer cell line: Panc-1. Turkish Journal of Pharmaceutical Sciences 2023; 0(0) doi: 10.4274/tjps.galenos.2023.86727
|
| 24 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 2022; 14(10) doi: 10.3390/cancers14102486
|
| 25 |
Zhaokai Li, Ruobei Shu, Meichai Li, Xinyv Wang, Xinmei Chen, Hang Chen, Xin Wu, Jianping Chen. Recent progress in gemcitabine-loaded nanoparticles for pancreatic cancer therapy: a review. Nanoscale 2025; 17(30) doi: 10.1039/D5NR02005K
|